Fascin-1 as a novel diagnostic marker of triple-negative breast cancer.
about
Fascin expression is inversely correlated with breast cancer metastasis suppressor 1 and predicts a worse survival outcome in node-negative breast cancer patients.FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer.EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.Fascin is secreted in male's serum: results of a pilot study.HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer.
P2860
Fascin-1 as a novel diagnostic marker of triple-negative breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fascin-1 as a novel diagnostic marker of triple-negative breast cancer.
@en
Fascin-1 as a novel diagnostic marker of triple-negative breast cancer.
@nl
type
label
Fascin-1 as a novel diagnostic marker of triple-negative breast cancer.
@en
Fascin-1 as a novel diagnostic marker of triple-negative breast cancer.
@nl
prefLabel
Fascin-1 as a novel diagnostic marker of triple-negative breast cancer.
@en
Fascin-1 as a novel diagnostic marker of triple-negative breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Fascin-1 as a novel diagnostic marker of triple-negative breast cancer.
@en
P2093
Bi-Fei Huang
Chao-Qun Wang
Chen-Ming Su
Chih-Hsin Tang
Hao-Teng Chang
Xiao-Ni Li
Xin-Xin Sun
P2860
P304
P356
10.1002/CAM4.746
P407
P577
2016-05-17T00:00:00Z